MedTrace Logo

Electrical Stimulation for the Treatment of Optic Neuropathies

NCT05626426 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-07-08

No results posted yet for this study

Summary

The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your eye pressure.

Conditions

  • Glaucoma
  • Glaucoma, Open-Angle
  • Optic Nerve Diseases

Interventions

DEVICE

Repetitive, Transorbital Alternating Current Stimulation (rtACS)

Patients receive treatment every other day via a headband that delivers electrical stimulation to the retina

Sponsors & Collaborators

Principal Investigators

  • Jeffrey L Goldberg, MD PhD · Stanford University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-27
Primary Completion
2026-12-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05626426 on ClinicalTrials.gov